Literature DB >> 8393881

The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.

R Pasquali1, S Cantobelli, F Casimirri, M Capelli, L Bortoluzzi, R Flamia, A M Labate, L Barbara.   

Abstract

To investigate whether obese subjects with abdominal obesity may be characterized by hyperactivity of the hypothalamic-pituitary-adrenal axis, we examined two groups of obese women with a waist to hip ratio (WHR) lower than 0.80 (n = 13), therefore having peripheral body fat distribution (P-BFD), or a WHR higher than 0.85 (n = 12), thus having abdominal body fat distribution (A-BFD). A group of seven normal weight healthy women served as controls. All subjects underwent the following protocol study that included 1) measurement of daily urinary free cortisol excretion rate; 2) a CRF test (human CRF, 1 microgram/kg BW, as iv bolus), with blood samples taken at regular intervals for ACTH and cortisol determination; and 3) an ACTH test, performed by administering two boli of ACTH (Synacthen, 0.2 microgram/kg BW, iv), at 90-min intervals, with blood samples taken for cortisol determination. Each woman also had a control saline study. Basal levels of both ACTH and cortisol rose significantly after CRF administration in all groups, but this increase was significantly higher in A-BFD than in P-BFD and control women. A significant correlation was found between the incremental area of cortisol and that of ACTH during the CRF test (r = 0.502), but not between these parameters and WHR values. Although the cortisol increase after the ACTH test was higher in A-BFD than in the other groups, these differences were only significant at 60 min during the test and when the analysis for repeated measures was applied. On the contrary, the incremental cortisol area after the ACTH test was not significantly different in the three groups. Moreover, it was not significantly correlated with the incremental cortisol area after CRF test or WHR values. Daily urinary free cortisol excretion rates (per g creatinine), however, were significantly higher in A-BFD than in P-BFD and control women. These results, therefore, suggest that obese women with A-BFD may have hyperactivity of the hypothalamic-pituitary-adrenal axis. This abnormality could be central in origin, due to hypersecretion of CRF or ACTH; alternatively, it could represent an adaptive phenomenon secondary to a state of functional cortisol resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393881     DOI: 10.1210/jcem.77.2.8393881

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  73 in total

Review 1.  The adrenal and the metabolic syndrome.

Authors:  M S Golub
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls.

Authors:  Jennifer B Hillman; Lorah D Dorn; Tammy L Loucks; Sarah L Berga
Journal:  Metabolism       Date:  2011-09-23       Impact factor: 8.694

3.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

4.  Acute effects of stress-reduction Interactive Guided Imagery(SM) on salivary cortisol in overweight Latino adolescents.

Authors:  Marc J Weigensberg; Christianne Joy Lane; Oscar Winners; Thomas Wright; Selena Nguyen-Rodriguez; Michael I Goran; Donna Spruijt-Metz
Journal:  J Altern Complement Med       Date:  2009-03       Impact factor: 2.579

5.  Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.

Authors:  V Vicennati; L Ceroni; L Gagliardi; U Pagotto; A Gambineri; S Genghini; R Pasquali
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

6.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

7.  Cortisol Measures Across the Weight Spectrum.

Authors:  Melanie Schorr; Elizabeth A Lawson; Laura E Dichtel; Anne Klibanski; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2015-07-14       Impact factor: 5.958

Review 8.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

Review 9.  Hypercortisolism in obesity-associated hypertension.

Authors:  Amy G Varughese; Oksana Nimkevych; Gabriel I Uwaifo
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 10.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.